Tyra Biosciences Inc., a clinical-stage biotechnology company, will participate in a virtual fireside chat as part of the UBS Biotech Management Live Call Series on July 25, 2025. The event will focus on achondroplasia and growth disorders, with company management including CEO Todd Harris, CMO Doug Warner, MD, and CFO Alan Fuhrman participating.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA34287) on July 21, 2025, and is solely responsible for the information contained therein.